Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myocardial Infarction Type 2”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Not applicableNot Yet RecruitingNCT07706335
What this trial is testing

Insulin Resistance and Its Association With no Reflow Phenomenon After Primary PCI in Type II Diabetic STEMI Patients.

Who this might be right for
STEMINo-Reflow PhenomenonDiabetic Patient
Assiut University 100
Large-scale testing (Phase 3)Study completedNCT00968708
What this trial is testing

Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Who this might be right for
Diabetes Mellitus, Type 2Acute Coronary Syndrome
Takeda 5,380
Not applicableStudy completedNCT03913793
What this trial is testing

Aerobic Training in Post-MI Patients With DPN

Who this might be right for
Myocardial InfarctionDiabetes Mellitus, Type 2Diabetic Peripheral Neuropathy
Yousra Hisham Abdel Fattah 37
Large-scale testing (Phase 3)Study completedNCT01730534
What this trial is testing

Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events

Who this might be right for
Diabetes Mellitus, Non-Insulin-DependentHigh Risk for Cardiovascular Event
AstraZeneca 17,190
Not applicableUnknownNCT02248311
What this trial is testing

"Preventing Cardiovascular Ischemic Events and Arresting Their Consequences in Type 2 Diabetic Population

Who this might be right for
Type2 Diabetes MellitusMicroangiopathyNon Alcoholic Fatty Liver Disease+4 more
Hospital Universitari Vall d'Hebron Research Institute 260
Post-approval studies (Phase 4)Active Not RecruitingNCT00725127
What this trial is testing

Chronotherapy with Low-dose Aspirin for Primary Prevention

Who this might be right for
Type 2 Diabetes
University of Vigo 3,200
Not applicableStudy completedNCT06017544
What this trial is testing

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

Who this might be right for
Diabetes Mellitus, Type 2Myocardial Infarction
University of Campania Luigi Vanvitelli 257
Large-scale testing (Phase 3)Study completedNCT04838808
What this trial is testing

Rivaroxaban in Type 2 Myocardial Infarctions

Who this might be right for
Type II Myocardial Infarction
University of Alberta 8
Not applicableStudy completedNCT06407154
What this trial is testing

Chronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, 2nd Wave

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Failure+13 more
Universitätsklinikum Hamburg-Eppendorf 578
Not applicableLooking for participantsNCT07469943
What this trial is testing

The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness and Cardiac Deformation After Acute Myocardial Infarction

Who this might be right for
Myocardial Infarction (MI)Diabete Type 2
University of Athens 80
Large-scale testing (Phase 3)UnknownNCT03658031
What this trial is testing

Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction

Who this might be right for
PreDiabetesMyocardial InfarctionT2DM (Type 2 Diabetes Mellitus)+1 more
Hamad Medical Corporation 576
Not applicableStudy completedNCT03648424
What this trial is testing

Prediction of Findings From the Ongoing CAROLINA Trial Using Healthcare Database Analyses

Who this might be right for
Type 2 Diabetes Mellitus
Brigham and Women's Hospital 48,262
Post-approval studies (Phase 4)UnknownNCT06557811
What this trial is testing

Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction

Who this might be right for
Diabetic PatientsAcute Myocardial Infarction
University of Sao Paulo General Hospital 88
Not applicableStudy completedNCT03953651
What this trial is testing

Clinical Presentation and Outcomes in Patients at Risk of Type II Myocardial InfarctioN in the emerGency Department.

Who this might be right for
Myocardial Oxygenation ImbalanceMyocardial Infarction
Hospices Civils de Lyon 1,000
Large-scale testing (Phase 3)Study completedNCT01594333
What this trial is testing

Cardiovascular Inflammation Reduction Trial

Who this might be right for
Cardiovascular Disease
Brigham and Women's Hospital 4,786
Not applicableLooking for participantsNCT05770687
What this trial is testing

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

Who this might be right for
Myocardial InfarctionDiabetes Mellitus, Type 2
Kiyuk Chang 1,000
Post-approval studies (Phase 4)Study completedNCT03329261
What this trial is testing

Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg

Who this might be right for
Diabetes Mellitus, Type 2NSTEMI - Non-ST Segment Elevation MICoronary Angioplasty
Laboratoires Teriak 167
Post-approval studies (Phase 4)Study completedNCT00191282
What this trial is testing

Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Acute Myocardial Infarction
Eli Lilly and Company 1,116
Large-scale testing (Phase 3)WithdrawnNCT04057261
What this trial is testing

Effect of Liraglutide on the Metabolic Profile in Patients With Type 2 Diabetes and Cardiovascular Disease

Who this might be right for
Type 2 DiabetesCardiovascular Diseases
RWTH Aachen University
Not applicableUnknownNCT03103854
What this trial is testing

Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular Disease

Who this might be right for
Diabetes Mellitus, Type 2Myocardial InfarctionCoronary Artery Disease+2 more
Cambridge Cardiac Care Centre 500
Next Page